STOCKHOLM, July 22, 2011 /PRNewswire/ — Elekta users from
Europe, Asia, the Middle East, North America and Africa converged
on Hotel Hohe Dune in Warnemunde, Germany June 16-19 to participate
in Elekta’s fifth European Users’ Conference. Approximately 390
clinicians and scientists attended 31 presentations and workshops
given by Elekta users and company representatives on a wide range
of cancer management topics. The Users’ Conference was preceded by
the Elekta Stereotactic Users’ Meeting, June 15-16.
“We are pleased that the European Users’ Conference has evolved
to become an established, respected platform on which the absolute
forefront of modern radiation therapy is discussed,” says Olof
Sanden, Executive Vice President, Europe and AFLAME. “This meeting
continues to attract the most technologically and clinically
sophisticated physicians and scientists in this region of the world
to share experience and knowledge with peers.”
The scientific program included presentations on:
- The relative roles of 2D, 3D and 4D IGRT
- The efficiency and precision of Volumetric Modulated Arc
Therapy (VMAT) - MOSAIQ® Oncology Information System organization and
management - Patient positioning and motion management
- Single fraction and fractionated stereotactic cranial treatment
with Leksell Gamma Knife® Perfexion™ and
Extend™ - Clarity® soft tissue visualization
Umberto Ricardi, M.D., radiation oncologist at the University
Hospital of Turin was among several invited speakers. Dr. Ricardi
discussed Turin’s nine months of clinical experience with Elekta
Axesse™ as a dedicated system for stereotactic radiation
therapy and radiosurgery of body and brain tumors, and lately,
spine tumors as well. Radiation delivery in most cases is with
Elekta VMAT™.
“We have treated 190 patients for a total of 210 lesions, and my
impression is
‘/>”/>
